All cancer types
Results
Phase 1
This trial was done to see what happened to a drug called GSAO in the body. This trial was supported by Cancer Research UK.
Cancers need a blood supply to be able to grow. Research in the laboratory had shown that GSAO could help stop the growth of blood vessels (anti angiogenesis) in cancers. Researchers hoped that it would help stop angiogenesis and slow down or stop the growth of cancer in people.
The aims of this trial were to find out
The best dose of GSAO to give
The effect GSAO has on the body
About side effects of GSAO
How GSAO affects cancer cells
Recruitment start: 24 January 2008
Recruitment end: 5 March 2012
Please note: In order to join a trial you will need to discuss it with your doctor, unless otherwise specified.
Professor Gordon Jayson
Cancer Research UK (Centre for Drug Development)
Experimental Cancer Medicine Centre (ECMC)
This is Cancer Research UK trial number CRUKD/08/041.
Last reviewed: 18 Dec 2013
CRUK internal database number: 680
About Cancer generously supported by Dangoor Education since 2010. Learn more about Dangoor Education
Search our clinical trials database for all cancer trials and studies recruiting in the UK.
Meet and chat to other cancer people affected by cancer.
Questions about cancer? Call freephone 0808 800 40 40 from 9 to 5 - Monday to Friday. Alternatively, you can email us.
